子宫动脉介入化疗术联合刮宫术治疗瘢痕妊娠18例临床分析  

The Clinical Analysis of Uterine Artery Infusion Chemotherapy Combined with Curettage Surgery Scar Pregnancy in 18 Cases

作　　者：蔡敏[1] 王俊杰[1] 

机构地区：[1]包头医学院第一附属医院,内蒙古包头014010

出　　处：《内蒙古医学杂志》2015年第2期191-193,共3页Inner Mongolia Medical Journal

摘　　要：目的探讨子宫动脉化疗介入术联合刮宫术治疗剖宫产瘢痕妊娠的有效性和安全性。方法回顾性分析2010年6月至2014年6月本院确诊的剖宫产瘢痕妊娠18例,先行子宫动脉栓塞术结合动脉灌注甲氨蝶呤,随后行刮宫术。观察手术效果及并发症情况。结果 18例患者均被成功治愈。血β-人绒毛膜促性腺激素降至正常平均为13.7 d,平均手术出血46.0ml,平均住院时间3.2 d。结论子宫动脉介入化疗术结合刮宫术治疗子宫瘢痕妊娠有效性及安全性较高,并达到了微创的目地。Objective Uterine arterial chemoembolization combined with curettage tor etncacy ana satety of cesarean scar pregnancy intervention. Method A retrospective analysis from 2010 June to 2014 June in our hospital diagnosed 18 cases of cesarean scar pregnancy, The advance of uterine artery embolization with arterial perfusion of methotrexate, Then curettage. To observe the effect of the operation and complications. Results 18 patients were successfully cured, Serum beta human chorionic gonadotropin dropped to normal for an average of 13.7 days, The average operation hemorrhage 46.0 ml, The average hospitalization time was 3.2 days. Con- clusion Combined with curettage in the treatment of uterine scar the effectiveness and safety of higher preg- nancy uterine artery interventional chemotherapy, and achieves the purpose of minimally invasive.

关 键 词：子宫动脉 甲氨蝶呤 瘢痕妊娠 刮宫术 

分 类 号：R714.22[医药卫生—妇产科学]